Australia markets closed

agilon health, inc. (AGL)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
3.2200-0.1000 (-3.01%)
At close: 04:00PM EDT
3.3000 +0.08 (+2.48%)
Pre-market: 08:18AM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-298,615
-262,596
-106,553
-406,487
-60,052
-
Depreciation & amortisation
22,208
20,161
13,772
14,670
14,099
-
Deferred income taxes
-
0
532
-3,231
-2,809
-
Stock-based compensation
71,367
69,495
28,381
292,394
6,688
-
Change in working capital
34,578
-10,067
-59,435
-55,025
6,472
-
Accounts receivable
-
-
-
-
-59,381
-23,280
Accounts payable
-
473,611
173,449
95,699
67,305
-
Other working capital
-186,188
-187,014
-163,469
-161,585
-55,554
-
Other non-cash items
-2,559
-4,044
3,526
1,763
3,313
-
Net cash provided by operating activities
-140,677
-156,199
-130,808
-148,159
-53,204
-
Cash flows from investing activities
Investments in property, plant and equipment
-45,511
-30,815
-32,661
-13,426
-2,350
-
Acquisitions, net
-885
-45,252
0
-1,344
-
-
Purchases of investments
-61,095
-114,657
-458,265
0
0
-
Sales/maturities of investments
182,518
164,040
52,548
7,095
2,058
-
Other investing activities
-20,802
-19,528
-6,510
-82,831
-3,847
-
Net cash used for investing activities
56,418
-44,019
-444,388
-90,506
22,066
-
Cash flows from financing activities
Debt repayment
-5,000
-5,000
-5,000
-119,899
-3,041
-
Common stock issued
4,410
11,867
33,056
1,189,028
34,404
-
Common stock repurchased
0
-200,000
0
0
-6,742
-
Other financing activities
-
-
-
-14,739
-
-303
Net cash used provided by (used for) financing activities
-590
-193,133
28,056
1,154,390
24,621
-
Net change in cash
-84,849
-393,351
-547,140
915,725
-6,517
-
Cash at beginning of period
201,185
507,680
1,054,820
139,095
145,612
-
Cash at end of period
116,336
114,329
507,680
1,054,820
139,095
-
Free cash flow
Operating cash flow
-140,677
-156,199
-130,808
-148,159
-53,204
-
Capital expenditure
-45,511
-30,815
-32,661
-13,426
-2,350
-
Free cash flow
-186,188
-187,014
-163,469
-161,585
-55,554
-